Over the years, novel drug reconstitution
systems have been widely adopted in the healthcare sector, owing to the
numerous benefits offered by these products. During our research, we identified
over 55 novel
drug reconstitution systems, including prefilled syringes, cartridges and
infusion bags being manufactured to ease the reconstitution of drugs packaged
in containers.
To order this detailed 180+ page report, please visit this - https://www.rootsanalysis.com/reports/drug-reconstitution-systems-market.html
Majority
of the companies (32%) engaged in this domain are very large players. Examples of such companies
include (in
alphabetical order, established after 1900)
Baxter, Fresenius Kabi, ICU Medical, Shandong Pharmaceutical Glass, Terumo,
Vetter Pharma and West Pharmaceutical Services. This is followed by the share
of mid-sized players (29%) in this domain. Prominent examples of mid-sized players
include (in alphabetical order, established after 2000) ADIENNE, Kapsam, and Taian Youlyy Industrial. Further, majority of the
companies (47%) engaged in this domain are located in Europe, particularly in Germany.
This is followed by the players based in
Asia-Pacific region with
Japan and South Korea being the most prominent countries. Within North America,
US emerged as the leading region, with the presence of seven companies.
As can be observed in the figure, majority
of the prefilled syringes (37.5%) and infusion bags (28.6%) are dual chamber
systems. On the other hand, around 18% of the infusion bags are multi
chambered. Further, the cartridges are available with single and dual chambers,
which make the administration of lyophilized drugs possible in an efficient and
convenient manner. Further, most of the prefilled syringes have capacity of
1-2.5 mL.
As can be observed in the figure, plastic
(57%) emerged as the most popular type of container fabrication material used
in novel drug reconstitution systems. Ethylene vinyl acetate (EVA) emerged as
the preferred plastic type used for the fabrication of majority (41%) of novel
drug reconstitution system containers. EVA is a hydrophobic polymer that offers
great flexibility and does not require solvents for drug delivery. Polypropylene,
having demonstrated good impact strength and improved resistance to moisture,
is the next popular material used in the manufacturing of novel drug
reconstitution systems.
To Request for sample - https://www.rootsanalysis.com/reports/drug-reconstitution-systems-market/request-sample.html
As can be seen in the figure, Nipro and
SCHOTT-KAISHA emerged as the most prominent players in this domain, developing
four novel drug reconstitution systems each. It is worth mentioning that Nipro
offers all the three types of novel drug reconstitution systems, namely- dual
chamber prefilled syringe (2), dual chamber cartridge (1), and dual chamber
infusion bag.
You may also be interested in the following titles:
1.
1DNA-Encoded Libraries: Platforms
and Services Market, 2020–2030
2.
Antibody Contract
Manufacturing Market, 2020 – 2030
3.
Global Autoinjectors
Market, 2020-2030
About Roots Analysis
Roots Analysis is one of the fastest
growing market research companies, sharing fresh and independent perspectives
in the bio-pharmaceutical industry. The in-depth research, analysis and
insights are driven by an experienced leadership team which has gained many
years of significant experience in this sector. If you’d like help with your
growing business needs, get in touch at info@rootsanalysis.com
Contact Details
Ben Johnson
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
Roots Analysis
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis.com
Medium: https://medium.com/@RootsAnalysis
Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/
Quora: https://rootsanalysisinsights.quora.com/
Comments
Post a Comment